In vivo relevance of bystander and non-targeted effects

46

No. 880 in all physics · No. 41 in Medical and Radiation Physics

Non-expert version

Determine whether bystander signalling, genomic instability and abscopal responses change organ-level risk at doses below 10 rad in vivo, relative to the prediction from directly hit cells alone. Required: dose range, signalling distance in tissue, and persistence. An answer is a quantified modification factor or a demonstration that it is negligible.

What would settle it

In vivo experiments with spatially restricted irradiation, such as microbeam or partial-body exposure, measuring effects in unirradiated tissue at low dose.

No solutions, ideas or subproblems yet.

How results are checked

See also

Comments (0)

Comments are not records: they are not signed, stamped or logged. How comments work

No comments yet.

Sign in to comment.

Details, signature and history
Kind
Well-posed question
Answer
Yes no
Posed
1992
Topic review
Brenner et al., Cancer risks attributable to low doses of ionizing radiation: assessing what we really know, Proceedings of the National Academy of Sciences, 2003. Link
Record
Revision 1 · imported from the seed collection · compiled by AI, not yet reviewed by an editor

Proof

Fingerprint
7a2b342b400c…
Public log
Entry 1,700, in checkpoint 2,123
In the log by
Block 969,698, 2026-10-03

This text was in the PubPhys log by that date. The date says nothing about when the problem was first posed.

History